Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma
Rachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Pediatric Blood & Cancer
|
December 27, 2019
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia
Jinhan Xie, Miriam Span, Erik van Maarseveen, et al.
Molecular Cancer Therapeutics
|
October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
Karen E Parrish, Ling Cen, James Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
E Ruth Plummer, Mark R Middleton, Christopher Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors
Ruth Plummer, Laura Vidal, Melanie Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2014
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study
Lucas Moreno, Lynley V Marshall, Andrew D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
Gareth J Veal, Michael Cole, Julie Errington, et al.
Blood Advances
|
January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL
Harry J Iland, John Reynolds, Alan V Boddy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2016
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
David Jamieson, Melanie J Griffin, Julieann Sludden, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 19, 2019
Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort
Xiaoman Liu, Siew-Kee Low, Joshua R Atkins, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2009
Inhibition of poly(ADP-ribose) polymerase-1 enhances temozolomide and topotecan activity against childhood neuroblastoma
Rachel A Daniel, Agata L Rozanska, Huw D Thomas, et al.
Pediatric Blood & Cancer
|
December 27, 2019
Optimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemia
Jinhan Xie, Miriam Span, Erik van Maarseveen, et al.
Molecular Cancer Therapeutics
|
October 7, 2015
Efficacy of PARP Inhibitor Rucaparib in Orthotopic Glioblastoma Xenografts Is Limited by Ineffective Drug Penetration into the Central Nervous System
Karen E Parrish, Ling Cen, James Murray, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2005
Temozolomide pharmacodynamics in patients with metastatic melanoma: dna damage and activity of repair enzymes O6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1
E Ruth Plummer, Mark R Middleton, Christopher Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors
Ruth Plummer, Laura Vidal, Melanie Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2014
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK study
Lucas Moreno, Lynley V Marshall, Andrew D J Pearson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study
Gareth J Veal, Michael Cole, Julie Errington, et al.
Blood Advances
|
January 28, 2025
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL
Harry J Iland, John Reynolds, Alan V Boddy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 4, 2016
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours
David Jamieson, Melanie J Griffin, Julieann Sludden, et al.
The Australian and New Zealand Journal of Psychiatry
|
November 19, 2019
Wnt receptor gene <i>FZD1</i> was associated with schizophrenia in genome-wide SNP analysis of the Australian Schizophrenia Research Bank cohort
Xiaoman Liu, Siew-Kee Low, Joshua R Atkins, et al.
Page
of 9